NAKA

Nakamoto Inc. Common Stock (NAKA)

Stock · NASDAQ · Health Care

$7.16as of 10/16/2026

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 29, 2026

Nakamoto Inc. Faces Crypto Regulatory Boost and Analyst Target Rise. The recent Trump‑Xi meeting and the SEC’s tokenization rule are viewed as near‑term catalysts for crypto‑related stocks, which could benefit Nakamoto Inc. B. Riley Securities has kept a positive stance, raising its price target to $13, in line with the broader analyst consensus of $13.33. The stock is currently near its 200‑day moving average and shows high beta, indicating sensitivity to market swings.

Active signals

Support level
$3.91
Industry
Medical/Nursing Services

What NAKA's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.

SignalTimesMedian 20-session returnHigher after 20 sessions
Volume Spike12-23.3%33%
Bollinger Band Breakout7-28.8%29%
Bollinger Band BreakdownActive now7-7.1%29%
Any 20-session window (baseline)-16.0%28%

Computed by MarketWall from daily closing prices since March 19, 2025. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.

About NAKA

Nakamoto Inc. develops and invests in a global portfolio of Bitcoin-native companies. It offers commercial and financial infrastructure for the capital markets. The company was formerly known as Kindly MD, Inc. and change its name to Nakamoto Inc. in January 2026. Nakamoto Inc. was incorporated in 2019 and is based in Nashville, Tennessee.

Sector
Health Care
Industry
Medical/Nursing Services
Employees
33

Fundamentals

1-day range
$7.61$8.18
Market cap
$86.14M
P/E (trailing)
—
P/E (forward)
—
EPS (trailing)
$-24.86
Dividend yield
—
Beta
1.57
Avg. volume
192.6K
52-week range
$3.33$42
Next earnings: August 14, 2026 · EPS estimate $0.40

How Nakamoto Inc. Common Stock Makes Money

Where the revenue actually goes — FY2025 annual results

market-wall.comTotalRevenue$1.82MSG&A$11.76M (646%)NAKA

Source: 10-K filed Mar 30, 2026 · via SEC EDGAR / Finnhub

Operating Income-$197.14M(-10824%)

Forecasts

3 analyst ratings

Buy 89%
Hold 11%
Sell 0%
1-year price forecast
High
$17
+137.6%
Median
$13
+81.7%
Low
$10
+39.8%

Nakamoto Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • NAKA
    Nakamoto Inc. Common Stock
    $7.13
    ▼ 11.87%
    Market cap $86.14MP/E —
    $3.33$42
  • PIII
    P3 Health Partners Inc. Class A Common Stock
    $4.14
    ▲ 0.00%
    Market cap $78.90MP/E —
    $1.52$16.89
  • ALPS
    ALPS Group Inc Ordinary Share
    $0.34
    ▲ 0.29%
    Market cap $69.06MP/E —
    $0.2293$12.01
  • DCGO
    DocGo Inc. Common Stock
    $0.272
    ▼ 3.55%
    Market cap $61.74MP/E —
    $0.2711$1.65
  • EUDA
    EUDA Health Holdings Limited Ordinary Shares
    $15.4
    ▼ 0.58%
    Market cap $48.78MP/E —
    $5.26$86
  • CCM
    Concord Medical Services Holdings Limited American Depositary Shares (Each represents thirty (30) Class A ordinary shares)
    $3.63
    ▼ 2.16%
    Market cap $21.53MP/E —
    $2.79$6.96
  • BMGL
    Basel Medical Group Ltd Ordinary Shares
    $3.95
    ▲ 1.02%
    Market cap $8.92MP/E —
    $2.56$21.72

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Insider Activity

Insider Actions →
Acquired
510.8K
Disposed
164.4K

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.